Company Filing History:
Years Active: 2016
Title: Marie Bugarel: Innovator in Molecular Risk Assessment
Introduction
Marie Bugarel is a notable inventor based in Pont du Casse, France. She has made significant contributions to the field of molecular risk assessment, particularly in relation to complex polymicrobial samples suspected to contain enterohemorrhagic E. coli (EHEC). Her innovative work has led to the development of a patented process that enhances the detection and assessment of these harmful pathogens.
Latest Patents
Marie Bugarel holds a patent for an "Assay for determining a molecular risk assessment of a complex polymicrobial sample suspected to contain an EHEC." This invention outlines a process that involves contacting a sample or its isolated DNA with specific primers derived from target genes such as stx1, stx2, eae, and espk. The process is characterized by a two-step approach that allows for the detection of amplification products for each target gene, thereby facilitating a comprehensive molecular risk assessment.
Career Highlights
Throughout her career, Marie has worked with prominent organizations, including the Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail. Her expertise in molecular biology and risk assessment has positioned her as a key figure in her field.
Collaborations
Marie Bugarel has collaborated with esteemed colleagues such as Patrick Fach and Lothar Beutin. These partnerships have further enriched her research and contributed to advancements in the understanding of EHEC and related pathogens.
Conclusion
Marie Bugarel's innovative contributions to molecular risk assessment highlight her dedication to improving public health through scientific research. Her patented processes and collaborations with leading experts underscore her impact in the field.